Tremfya Data Show Greater Treatment Persistence for Patients With Plaque Psoriasis
In an additional post-hoc analysis, guselkumab demonstrated improvements at week 48, according to Janssen Pharmaceutical.
Source: pharmacytimes.com
Scan Research Databases News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Scan Research Databases. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Scan Research Databases Today - Breaking & Trending Today
TREMFYA® (guselkumab) Real-World Data Analyses Show Greater Treatment Persistence Than IL-17s in Both Bio-naïve and Bio-experienced Patients Living With Moderate to Severe Plaque Psoriasis
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data, showing that initiation of TREMFYA® (guselkumab) was...
Source: prnewswire.com
Opioid Prescription Trends Show Decline in Use for Cancer, Noncancer Pain
Insurance claims data show rates of opioid prescriptions for pain management in cancer or chronic noncancer setting decreased from 2012 to 2019.
Source: oncologynurseadvisor.com
Opioid Rx Down for Chronic Noncancer Pain, Cancer Pain in U.S. Adults
Opioid prescribing declined for both chronic noncancer pain (CNCP) and cancer pain between 2012 and 2019.
Source: oncologynurseadvisor.com
Opioid Rx Down for Chronic Noncancer Pain, Cancer Pain in U.S. Adults
Opioid prescribing declined for both chronic noncancer pain and cancer pain between 2012 and 2019, according to a new study.
Source: cancertherapyadvisor.com